Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Gilead

March 24, 2020 CD derivatives / Pharma applications

University Hospitals in US to conduct coronavirus clinical trials

University Hospitals in Cleveland, US is set to conduct two clinical trials of remdesivir to treat adult Covid-19 patients hospitalised

Continue reading

March 12, 2020 CD derivatives / Pharma applications / Uncategorized

Hundreds of Virus Patients Allowed to Try Gilead’s Ebola Drug

Hundreds of coronavirus patients have been treated with Gilead’s experimental Ebola treatment under an FDA program to allow access to

Continue reading

March 1, 2020 CD as API / CD derivatives / In Hungarian / Pharma applications

A CycloLab Kft. felveszi a kesztyűt a koronavírus elleni harcban

Az új koronavírus (SARS-CoV-2) okozta megbetegedés (COVID-19) mára több, mint 65 országot és területet érint, majd 90000 regisztrált megbetegedéssel és

Continue reading

March 1, 2020 CD as API / CD derivatives / Pharma applications / Uncategorized

CycloLab picks up the gauntlet to fight coronavirus

The novel coronavirus SARS-CoV-2 is affecting 65 countries and territories around the world with almost 90,000 reported cases and almost

Continue reading

February 27, 2020 CD derivatives / Pharma applications / Uncategorized

Gilead Sciences Initiates Two Phase 3 Studies of Investigational SBECD-enabled Antiviral Remdesivir for the Treatment of COVID-19

Gilead Sciences, Inc. yesterday announced the initiation of two Phase 3 clinical studies to evaluate the safety and efficacy of

Continue reading

February 3, 2020 CD derivatives / Drug delivery / Pharma applications

Gilead uses SBECD-enabled remdesivir (GS-5734) for treating the first case of the 2019 novel coronavirus in the United States

Gilead Sciences’ SBECD-enabled remdesivir (GS-5734) was highlighted in the New England Journal of Medicine last week for treating the first

Continue reading

Posts pagination

«Previous Posts 1 2 3 4

Recent Posts

  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • 2 nd International Conference on Biomedical Science and Engineering
  • Sugammadex vs Neostigmine: Effects on Obese Patients’ Recovery
  • Cyclodextrin-Amino Acid Conjugates
  • Cyclodextrin complexation of selected tyrosine kinase inhibitors

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (343)
  • CD derivatives (404)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (784)
  • E-ducation (63)
  • Environmental (132)
  • Events (233)
  • Food (219)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (396)
  • Other industrial use (104)
  • Pharma applications (1,172)
  • Supramolecular systems (40)
  • Uncategorized (143)

Top Posts

  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • Cyclodextrin-Amino Acid Conjugates
  • Cyclodextrin-in-Liposome for therapy: Advances and challenges
  • Pilocarpine eye drops (Vuity)
  • Lanosterol eye drops for cataract treatment
  • Characterization of the substitution pattern of 2-hydroxypropyl-β-cyclodextrin using NMR spectroscopy
  • CDs for the removal of PFAS; A review
  • Cyclodextrins Meet Cosmetics, a review
  • Appropriate Dosing of Sugammadex in Morbidly Obese Patients
  • Water-Soluble EDTA-Crosslinked Poly-β-Cyclodextrins as Ion-Complexing Drug Carriers.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,791 other subscribers

Loading Comments...